Special Issue

NanoTheranostics

Guest editors:

Jun Wang, PhD
School of Life Sciences
University of Science and Technology of China (USTC)
Email:
http://nanomedicine.ustc.edu.cn/yys_1/

Honggang Cui, PhD
Department of Chemical and Biomolecular Engineering
Whiting School of Engineering
The Johns Hopkins University
Email:
http://www.jhu.edu/cui

Therapeutics and diagnostics go hand in hand for the treatment and handling of many diseases. A theranostic system could be interpreted as a synergetic combination of therapeutic compounds with diagnostic agents that promises better prognosis and improved treatment. Over the past three decades, extensive research in cancer nanomedicine has led to significant progress in the development of many nanocarrier-based platform technologies. However, the lack of FDA approval for carrier-based nanomedicine underscores the unmet challenges in the field. As we reflect on the successes and failures of past nanomedicine research, it is equally essential for the community to lay out future directions that promise far more effective cancer chemotherapies. One potential avenue could be the concomitant or tandem use of diagnostic and therapeutic agents for personalized treatments of cancer. Indeed, advancements in the development of new imaging techniques and novel types of molecular probes have made it possible for more accurate tumor detection, cancer staging, and real-time monitoring of cancer progression and therapeutic outcomes.

The goal of this themed issue on NanoTheranostics is to invite leading experts in the fields of nanoscience, cancer nanomedicine, diagnostics, and imaging, to discuss their most recent discoveries in associated topics, and to share their vision on the future development of this emerging field. Unsolicited submissions are also welcome.
Topics include, but are not limited to:

Nanoparticle Platforms for Theranostics
Imaging-Guided Drug Delivery Systems
Cancer Nanomedicine
Nanoprobes and Contrast Agents
Theranostics-Based Personalized Medicine
Nanosensors for Biomarker Detection

Both reviews and research articles will be considered.

The issue is planned for distribution to the participants of the 1st International Symposium for Chinese American Society of Nanomedicine and Nanobiotechnology (CASNN) to be held in Beijing, China in the summer of 2016. Please note that while the CASNN inaugural symposium serves as the major motivation prompting the initiation of this thematic topic, the issue is not related to the Symposium, nor is it part of the Conference Proceedings. Although strongly encouraged, the authors are not required to attend the inaugural CASNN symposium by contributing to this Special Issue. All invited and contributed manuscripts will undergo the standard peer-review procedure of the Journal “Theranostics”, and be scrutinized by the guest editors and at least two additional expert reviewers in the field. The manuscript submission DEADLINE is set for January 1st, 2016 and the first decision will be made within 6 weeks from submission, after the peer-review process.

Manuscripts for the special issue can be sent directly to the guest editor(s) by email with the subject "NanoTheranostics Special Issue", or submitted online at http://www.thno.org/ms/submit?subgroup=nanothno (mark "NanoTheranostics Special Issue" in the "Suggested reviewers" field to identify the paper).

Detailed formatting instructions, in particular, the formatting of references, can be found in http://www.thno.org/ms/author.

All inquiries should be sent to the guest editor(s) at the above email address.